 |
 |

Amniotic Membrane Transplantation in Human Immunodeficiency Virus–Positive Children
Paolo Capozzi, MD;
Chiara Morini, MD;
Pasquale Vadalà, MD
Arch Ophthalmol. 2008;126(6):866-867.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Amniotic membrane transplantation (AMT) is a beneficial and safe procedure in several ocular surface impairments.1 Reported adverse effects of AMT are pseudopterygium, postoperative bacterial ulcer, ocular discomfort, and fibrotic reaction.2-3 Goyal et al4 recently observed an organized amniotic membrane in a human immunodeficiency virus (HIV)–positive child after an AMT for symblepharon. We report a similar case of an HIV-positive patient treated with an AMT at our institution.
Methods
An HIV-positive 10-year-old girl with a history of herpetic keratitis and penetrating keratoplasty (January 2006) of the right eye was referred to our pediatric ophthalmology service in June 2006. At our examination, visual acuity was +1.7 logMAR (logarithm of minimum angle resolution) OD and 0.0 logMAR OS. The cornea had a central opacification that was deeply vascularized. A severe active corneal inflammation was present. Fundus examination in the right eye was not valuable. We . . . [Full Text of this Article] Results
Comment
AUTHOR INFORMATION
RELATED ARTICLE
Retinal Vessels and Retinopathy of Prematurity—Reply
Monte D. Mills, Graham E. Quinn, Juan E. Grunwald, Gui-Shuang Ying, Karen Karp, and Michael Rabinowitz
Arch Ophthalmol. 2008;126(6):869-870.
EXTRACT
| FULL TEXT
|